BRIEF-Karyopharm says top-line data from SADAL study expected in second half of 2018
* Karyopharm reports updated Phase 2b SADAL data for Selinexor in diffuse large B-cell lymphoma at the 2017 European Hematology Association Annual Meeting
JERUSALEM, March 13 Chipmaker Intel has agreed to buy Israeli technology firm Mobileye for $14-$15 billion dollars, according to TheMarker, one of Israel's leading financial newspapers.
The companies will announce the deal later on Monday, TheMarker reported on its website. Mobileye is a leading manufacturer of software for autonomous vehicles.
Intel and Mobileye were not immediately reachable for comment. (Reporting by Ari Rabinovitch; editing by Luke Baker)
LONDON, June 23 Investors pulled $7.7 billion from U.S. equities, the biggest outflows in five weeks, data from Bank of America Merrill Lynch (BAML) showed on Friday, reversing the previous week's bumper inflows as bears battled with the bulls.